argenx SE (ARGX)
984.39
+0.35
(+0.04%)
USD |
NASDAQ |
Sep 11, 16:00
984.80
+0.41
(+0.04%)
After-Hours: 20:00
argenx Enterprise Value : 60.85B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 60.85B |
| September 10, 2026 | 60.83B |
| September 09, 2026 | 61.96B |
| September 08, 2026 | 62.25B |
| September 04, 2026 | 63.87B |
| September 03, 2026 | 65.12B |
| September 02, 2026 | 65.24B |
| September 01, 2026 | 63.58B |
| August 31, 2026 | 63.77B |
| August 28, 2026 | 63.25B |
| August 27, 2026 | 65.46B |
| August 26, 2026 | 64.73B |
| August 25, 2026 | 63.02B |
| August 24, 2026 | 62.50B |
| August 21, 2026 | 64.28B |
| August 20, 2026 | 64.17B |
| August 19, 2026 | 63.85B |
| August 18, 2026 | 61.38B |
| August 17, 2026 | 61.06B |
| August 14, 2026 | 52.61B |
| August 13, 2026 | 52.96B |
| August 12, 2026 | 54.14B |
| August 11, 2026 | 53.45B |
| August 10, 2026 | 53.53B |
| August 07, 2026 | 53.46B |
| Date | Value |
|---|---|
| August 06, 2026 | 54.10B |
| August 05, 2026 | 53.64B |
| August 04, 2026 | 52.19B |
| August 03, 2026 | 51.34B |
| July 31, 2026 | 52.77B |
| July 30, 2026 | 53.93B |
| July 29, 2026 | 54.55B |
| July 28, 2026 | 53.91B |
| July 27, 2026 | 54.94B |
| July 24, 2026 | 56.75B |
| July 23, 2026 | 57.15B |
| July 22, 2026 | 52.64B |
| July 21, 2026 | 54.06B |
| July 20, 2026 | 52.30B |
| July 17, 2026 | 53.19B |
| July 16, 2026 | 53.03B |
| July 15, 2026 | 53.33B |
| July 14, 2026 | 53.12B |
| July 13, 2026 | 54.16B |
| July 10, 2026 | 54.24B |
| July 09, 2026 | 56.21B |
| July 08, 2026 | 56.57B |
| July 07, 2026 | 56.86B |
| July 06, 2026 | 56.67B |
| July 02, 2026 | 58.08B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Autolus Therapeutics Plc | 665.07M |
| Akari Therapeutics Plc | 12.72M |
| Forte Biosciences, Inc. | 1.378B |
| Evaxion AS | 19.21M |
| Grifols SA | 13.88B |
Enterprise Value Related Metrics
| Earnings Yield | 2.67% |
| Operating Earnings Yield | 2.34% |
| Normalized Earnings Yield | 2.665 |